Year: 2024
Type: article
Abstract: The approach to diabetic foot involves a multidisciplinary process, and the proteolytic enzyme collagenase has proven to be an invaluable ally for wound healing, with excellent tolerance. Interview with Dr. Mabel Carrió (M.N. 68739), diabetologist, director of the Dr. Alberto Maggio Municipal Diabetes Center and the Malvinas Argentinas Diabetic Foot Day Hospital, and director of the Diploma in Diabetic Foot, Universidad Nacional del Nordeste (UNNE). According to data from the International Diabetes Federation, more than 550 million people worldwide live with diabetes mellitus (DM),1 while in Argentina, based on data from the Fourth National Survey of Risk Factors (2019),2 it is clear that 12% of the population (5.5 million people) suffer from this condition. “Approximately 18.6 million people with DM develop a foot ulcer each year worldwide3, which means that around 2% to 3% of this population have an active foot ulcer4, while 34% of people with DM1 or DM2 will develop a foot ulcer throughout their life5, with an approximate incidence of 2% per year6”, contextualizes Dr. Mabel Carrió, Diabetologist, Director of the Dr. Alberto Maggio Municipal Diabetes Center and the Malvinas Argentinas Diabetic Foot Day Hospital.
Source: Lugones Editorial
Author: Cristoforetti, María Fernanda
Institution: Universidad de Buenos Aires
Language: Spanish
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7219946368